期刊文献+

抑癌基因Hes1影响急性髓系白血病细胞增殖和凋亡的机制研究 被引量:2

Inhibitory effects of Hes1 on acute myeloid leukemia cells
原文传递
导出
摘要 目的 阐明Hes1与急性髓系白血病(AML)细胞增殖和凋亡的关系.方法 通过实时定量PCR检测AML原代细胞和HL-60、U937、KG1a细胞中Hes1和p21的表达情况;通过在AML细胞中转染逆转录病毒载体使Hes1高表达,通过MTT及流式细胞术检测高表达Hes1的AML细胞增殖和细胞周期、凋亡的改变;并通过成瘤实验检测Hes1+AML细胞在NOD/SCID小鼠体内的增殖情况.结果 Hes1和p21在AML患者原代细胞和HL-60、U937、KG1a细胞中的表达分别为0.67±0.24和0.59±0.43、0.42±0.03和0.32±0.26、0.54±0.01和0.44±0.12、0.36±0.12和0.59±0.43,均较正常对照组水平降低(P值均<0.05);通过逆转录病毒载体诱导后HL-60、U937、KG1a细胞中Hes1的表达分别为4.9±0.2、5.2±0.4、5.8±0.5,均较未转染诱导前上调(P值均<0.05);感染Hes1后AML细胞与感染空载体的AML细胞比较,增殖受到抑制,细胞凋亡增加.与对照组比较,3种细胞系高表达Hes1后在NOD/SCID小鼠体内的成瘤性均降低(P值均<0.05).结论 Hes1过表达可抑制AML细胞的增殖,诱导AML细胞凋亡,从而提示Hes1为AML的抑制基因,可能成为治疗AML的新靶点. Objective To elucidate the impact of Hesl on the proliferation and apoptosis of acute myeloid leukemia (AML) cells.Methods The expression levels of Hesl and p21 in AML patient samples and myeloid leukemia cell lines were analyzed by real-time PCR.Hes1 was up-regulated by retrovirus transfection in AML cell lines and the proliferation capacity were assayed by MTT,cell cycle by Hoechst/PY,apoptosis by AnnexinV.Results The expression of Hes1 in primary AML cells and HL-60、U937 、KG1a cell lines were 0.67±0.24,0.59±0.43,0.42±0.03,and 0.32±0.26,respectively,and p21 were 0.54±0.01,0.44±0.12,0.36±0.12,and 0.59±0.43,respectively.Hes1 expression levels after transduction in HL-60、U937、KG1a were 4.9±0.2,5.2±0.4,5.8±0.5,respectively.Induced activation of Hesl led to AML cells growth arrest and apoptosis,which was associated with an enhanced p21 expression.Besides,activated Hes1 led to AML cells growth inhibition in vivo.Conclusions Hesl could mediate growth arrest and apoptosis in AML cells,which may be a novel target for AML.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2015年第6期485-488,共4页 Chinese Journal of Hematology
基金 国家自然科学基金(31301161、81270603) 天津市应用基础与前沿技术研究计划(13JCYBJC22800)
关键词 白血病 髓样 急性 基因 Hes1 细胞增殖 细胞凋亡 Leukemia, myeloid, acute Genes, Hes1 Cell proliferation Apoptosis
  • 相关文献

参考文献22

  • 1Aster JC1, Pear WS, Blacklow SC. Notch signaling in leukemia[J]. Annu Rev Pathol, 2008, 3:587-613.
  • 2Xu X, Zhao Y, Xu M, et al. Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia[J]. Med Oncol, 2011, 28:S483-S489.
  • 3Chadwick N, Nostro MC, Baron M, et al. Notch signaling induces apoptosis in primary human CD34+ hematopoietic progenitor cells[J]. Stem Cells, 2007, 25(1):203-210.
  • 4Lobry C, Oh P, Aifantis I. Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think[J]. J Exp Med, 2011, 208(10):1931-1935.
  • 5Li GH, Fan YZ, Liu XW, et al. Notch signaling maintains proliferation and survival of the HL60 human promyelocytic leukemia cell line and promotes the phosphorylation of the Rb protein[J]. Mol Cell Biochem, 2010, 340(1-2):7-14.
  • 6Lobry C, Ntziachristos P, Ndiaye-Lobry D, et al. Notch pathway activation targets AML initiating cell homeostasis and differentiation[J]. J Exp Med, 2013, 210(2): 301-319.
  • 7Kannan S, Sutphin RM, Hall MG, et al. Notch activation inhibits AML growth and survival: a potential therapeutic approach[J]. J Exp Med, 2013, 210(2): 321-337.
  • 8Nakahara F, Sakata-Yanagimoto M, Komeno Y, et al. Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia[J]. Blood, 2010, 115(14):2872-2881.
  • 9Tian C, Zheng G, Cheng T, et al. Hes1 protects the function of normal HSC in leukemic microenviroment[J]. Cell Cycle, 2013, 12 (2): 322-331.
  • 10Hu X, Shen H, Tian C, et al. Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model [J]. Blood, 2009, 114(18): 3783-3792.

同被引文献9

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部